U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 2, 2002 ------------- HUAYANG INTERNATIONAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 000-30173 58-1667944 (State or other) (Commission (I.R.S. Employer jurisdiction File Number) Identification Number) of incorporation 386 Qing Nian Avenue, Shenyang, China 110003 (Address of principal executive offices) (Zip code) 011 (86)(24) 2318-0688 (Issuer's telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Item 2. Acquisition or Disposition of Assets On April 2, 2003, Huayang International Holdings, Inc. (the "Company") rescinded the acquisition of Jiahe Medicine Group ("Jiahe") and cancelled the 1,900,000 restricted shares issued to Zheng Hongwei in connection with the acquisition. Item 5. Other Events and Regulation FD Disclosure On April 11, 2003, Huayang International Holdings, Inc. (the "Company") issued a press release announcing that it has rescinded the acquisition of Jiahe Medicine Group. A copy of the press release dated April 11, 2003 is attached as exhibit 99.1 hereto and incorporated herein by reference. Item 7. Exhibits 99.1 Press Release dated April 11, 2003. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized. Huayang International Holdings, Inc. Date: April 11, 2003 /s/ Gao WanJun ----------------- Name: Gao WanJun Title: President and Chief Executive Officer EXHIBIT INDEX Exhibit Number Description - ------- ----------- 99.1 Press release, dated April 11, 2003, of Huayang International Holdings, Inc.